ANI Pharmaceuticals, Inc. (ANIP) earnings
ANIP earnings moved a median of +0.69% by the close. Quarterly and annual ANIP reports and results, each read against the price at its own news timestamp. Back to the ANIP overview →
30 measured ANIP earnings events.
Where these ANIP earnings landedvs 30 measured ANIP earnings reactions
| Middle 50% of ANIP earnings reactions | -2.79% to +3.61% |
|---|---|
| Median reaction (to close) | +0.69% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 ANIP earnings events with a measured close landed between -2.79% and +3.61%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results | Press release | -3.58% | +1.50% | |
| Form 10-Q ANI PHARMACEUTICALS INC For: Jun 30 | SEC filing · Form 10-Q | -3.58% | +1.50% | |
| ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET | Press release | -0.65% | -1.76% | |
| ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance | Press release | -6.10% | -6.72% | |
| Form 10-Q ANI PHARMACEUTICALS INC For: Mar 31 | SEC filing · Form 10-Q | -6.10% | -6.72% | |
| ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET | Press release | +0.73% | +0.98% | |
| Form 10-K ANI PHARMACEUTICALS INC For: Dec 31 | SEC filing · Form 10-K | -3.22% | -5.07% | |
| ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance | Press release | +4.56% | +5.42% | |
| Form 10-Q ANI PHARMACEUTICALS INC For: Sep 30 | SEC filing · Form 10-Q | +4.56% | +5.42% | |
| ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET | Press release | +0.27% | -0.98% | |
| ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance | Press release | +3.60% | +4.65% | |
| Form 10-Q ANI PHARMACEUTICALS INC For: Jun 30 | SEC filing · Form 10-Q | +3.60% | +4.65% | |
| ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET | Press release | -0.55% | +1.28% | |
| ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance | Press release | -4.79% | -13.84% | |
| Form 10-Q ANI PHARMACEUTICALS INC For: Mar 31 | SEC filing · Form 10-Q | -4.79% | -13.84% | |
| ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET | Press release | -0.72% | +6.02% | |
| Form 10-K ANI PHARMACEUTICALS INC For: Dec 31 | SEC filing · Form 10-K | -3.34% | +0.41% | |
| ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance | Press release | -4.89% | -0.23% | |
| Form 10-Q ANI PHARMACEUTICALS INC For: Sep 30 | SEC filing · Form 10-Q | -4.89% | -0.23% | |
| ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET | Press release | +0.00% | -1.57% | |
| ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance | Press release | -1.10% | +4.09% | |
| Form 10-Q ANI PHARMACEUTICALS INC For: Jun 30 | SEC filing · Form 10-Q | -1.10% | +4.09% | |
| ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET | Press release | +0.00% | +1.86% | |
| ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance | Press release | -5.10% | -2.79% | |
| Form 10-Q ANI PHARMACEUTICALS INC For: Mar 31 | SEC filing · Form 10-Q | -5.10% | -2.79% | |
| ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET | Press release | +0.00% | +1.99% | |
| Form 10-K ANI PHARMACEUTICALS INC For: Dec 31 | SEC filing · Form 10-K | +0.78% | +4.92% | |
| ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance | Press release | -3.35% | -10.94% | |
| Form 10-Q ANI PHARMACEUTICALS INC For: Sep 30 | SEC filing · Form 10-Q | -3.35% | -10.94% | |
| ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET | Press release | +0.00% | +2.17% |
Keep exploring
More ANIP: analyst actions → · SEC filings → · ANIP overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Teligent, Inc. (TLGT) | 502 | -0.17% | 43% |
| Zealand Pharma A/S - American Depositary Shares (ZEAL) | 501 | 0.00% | 40% |
| ARGOS THERAPEUTICS (ARGS) | 498 | -0.22% | 39% |
| BIOANALYTICAL SYSTEMS (BASI) | 498 | 0.00% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.